For: | Kim YS, Kim TH, Choi CS, Shon YW, Kim SW, Seo GS, Nah YH, Choi MG, Choi SC. Effect of itopride, a new prokinetic, in patients with mild GERD: A pilot study. World J Gastroenterol 2005; 11(27): 4210-4214 [PMID: 16015691 DOI: 10.3748/wjg.v11.i27.4210] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v11/i27/4210.htm |
Number | Citing Articles |
1 |
F. FORNARI, K. BLONDEAU, L. DURAND, E. REY, M. DIAZ‐RUBIO, A. DE MEYER, J. TACK, D. SIFRIM. Relevance of mild ineffective oesophageal motility (IOM) and potential pharmacological reversibility of severe IOM in patients with gastro‐oesophageal reflux disease. Alimentary Pharmacology & Therapeutics 2007; 26(10): 1345 doi: 10.1111/j.1365-2036.2007.03525.x
|
2 |
Toru Hiyama, Masaharu Yoshihara, Shinji Tanaka, Ken Haruma, Kazuaki Chayama. Strategy for treatment of nonerosive reflux disease in Asia. World Journal of Gastroenterology 2008; 14(20): 3123-3128 doi: 10.3748/wjg.14.3123
|
3 |
Hyo Yeop Song, Sung Won Jung, Yong Sung Kim. Prokinetic Agents. The Korean Journal of Helicobacter and Upper Gastrointestinal Research 2022; 22(2): 86 doi: 10.7704/kjhugr.2022.0011
|
4 |
A. E. Babich, N. A. Zubareva, G. G. Ketova. Priorities in choosing prokinetic for patients with functional dyspepsia: Focus on itopride. Medical alphabet 2022; 1(28): 28 doi: 10.33667/2078-5631-2022-28-28-32
|
5 |
Carla Maradey-Romero, Ronnie Fass. Diagnosis and Treatment of Gastroesophageal Reflux Disease. 2016; : 93 doi: 10.1007/978-3-319-19524-7_6
|
6 |
Kalani Olmsted, Deborah B. Diercks. Emergency Department Analgesia. 2008; : 225 doi: 10.1017/CBO9780511544835.033
|
7 |
Makiko Shimizu, Shotaro Uehara, Hiroshi Suemizu, Hiroshi Yamazaki. In vivo drug interactions of itopride and trimethylamine mediated by flavin-containing monooxygenase 3 in humanized-liver mice. Drug Metabolism and Pharmacokinetics 2021; 37: 100369 doi: 10.1016/j.dmpk.2020.11.004
|
8 |
Byung-Joon Chun, Dong-Soo Lee. The effect of itopride combined with lansoprazole in patients with laryngopharyngeal reflux disease. European Archives of Oto-Rhino-Laryngology 2013; 270(4): 1385 doi: 10.1007/s00405-012-2341-8
|
9 |
E. Scarpellini, A. Pauwels, R. Vos, N. Rommel, J. Tack. Effect of methylnaltrexone and naloxone on esophageal motor function in man. Neurogastroenterology & Motility 2017; 29(3) doi: 10.1111/nmo.12938
|
10 |
E. Scarpellini, R. Vos, K. Blondeau, V. Boecxstaens, R. Farré, A. Gasbarrini, J. Tack. The effects of itopride on oesophageal motility and lower oesophageal sphincter function in man. Alimentary Pharmacology & Therapeutics 2011; 33(1): 99 doi: 10.1111/j.1365-2036.2010.04487.x
|
11 |
Abdulaziz N. Amro. Voltammetric Method Development for Itopride Assay in a Pharmaceutical Formulation. Current Pharmaceutical Analysis 2020; 16(3): 312 doi: 10.2174/1573412915666190912122421
|
12 |
Kenji Koshino, Kyoichi Adachi, Kenji Furuta, Masahito Aimi, Kousuke Fukazawa, Shino Shimura, Terumi Morita, Shuji Nakata, Shunji Ohara, Takashi Tanimura, Masaharu Miki, Yoshikazu Kinoshita. Effects of nizatidine and itopride hydrochloride on esophageal motor function. Esophagus 2011; 8(4): 253 doi: 10.1007/s10388-011-0289-1
|
13 |
Toshihisa Takeuchi, Kazuhide Higuchi. Clinical Trials about the Gastroesophageal Reflux Disease. Nihon Naika Gakkai Zasshi 2013; 102(6): 1511 doi: 10.2169/naika.102.1511
|
14 |
V. T. Ivashkin, A. S. Trukhmanov, I. V. Maev, O. M. Drapkina, M. A. Livzan, A. I. Martynov, T. L. Lapina, A. V. Paraskevova, D. N. Andreev, O. P. Alexeeva, S. A. Alekseenko, A. Yu. Baranovsky, O. V. Zayratyants, O. Yu. Zolnikova, O. B. Dronova, I. L. Kliaritskaia, N. V. Korochanskaya, Yu. A. Kucheryavyy, S. N. Mammaev, M. F. Osipenko, S. S. Pirogov, E. A. Poluektova, D. E. Rumyantseva, R. G. Sayfutdinov, O. A. Storonova, Yu. P. Uspenskiy, I. B. Khlynov, V. V. Tsukanov, A. A. Sheptulin. Diagnosis and Treatment of Gastroesophageal Reflux Disease (Clinical Guidelines of the Russian Gastroenterological Association, Russian Scientific Medical Society of Internal Medicine, Russian Society for the Prevention of Noncommunicable Diseases, Scientific Community for Human Microbiome Research). Russian Journal of Gastroenterology, Hepatology, Coloproctology 2024; 34(5): 111 doi: 10.22416/1382-4376-2024-34-5-111-135
|
15 |
A. V. Paraskevova, A. S. Trukhmanov, O. A. Storonova, S. V. Lyamina, S. V. Kalish, S. S. Pirogov, A. B. Ponomarev, D. E. Rumyantseva, I. Yu. Malyshev, I. V. Maev, V. T. Ivashkin. Macrophage phenotype after human refluxate exposure, esophageal dysmotility and their correlation with gastroesophageal reflux disease. Russian Journal of Gastroenterology, Hepatology, Coloproctology 2022; 32(1): 24 doi: 10.22416/1382-4376-2022-32-1-24-33
|
16 |
Tiberiu Hershcovici, Ronnie Fass. Gastro-Oesophageal Reflux Disease. Drugs 2011; 71(18): 2381 doi: 10.2165/11597300-000000000-00000
|
17 |
Awaji Y. Safhi, Waqar Siddique, Muhammad Zaman, Rai Muhammad Sarfraz, Muhammad Shafeeq Ur Rahman, Asif Mahmood, Ahmad Salawi, Fahad Y. Sabei, Abdullah Alsalhi, Khalid Zoghebi. Statistically Optimized Polymeric Buccal Films of Eletriptan Hydrobromide and Itopride Hydrochloride: An In Vivo Pharmacokinetic Study. Pharmaceuticals 2023; 16(11): 1551 doi: 10.3390/ph16111551
|
18 |
Sundeep Lakhtakia, Aniruddha P Singh, Neeraj Singla, Sana F Memon, Duvvur N Reddy. Efficacy and safety of pantoprazole and itopride in patients with overlap of gastroesophageal reflux disease and dyspepsia: A prospective, open‐label, single‐arm pilot study. JGH Open 2024; 8(2) doi: 10.1002/jgh3.12988
|
19 |
Kwong Ming Fock, Choo Hean Poh. Gastroesophageal reflux disease. Journal of Gastroenterology 2010; 45(8): 808 doi: 10.1007/s00535-010-0274-9
|
20 |
Yvan Vandenplas, Sébastien Kindt. Textbook of Pediatric Gastroenterology, Hepatology and Nutrition. 2022; : 125 doi: 10.1007/978-3-030-80068-0_10
|
21 |
Kwong Ming Fock, Nicholas J Talley, Ronnie Fass, Khean Lee Goh, Peter Katelaris, Richard Hunt, Michio Hongo, Tiing Leong Ang, Gerald Holtmann, Sanjay Nandurkar, San Ren Lin, Benjamin CY Wong, Francis KL Chan, Abdul Aziz Rani, Young‐Tae Bak, Jose Sollano, Lawrence KY Ho, Sathoporn Manatsathit. Asia‐Pacific consensus on the management of gastroesophageal reflux disease: Update. Journal of Gastroenterology and Hepatology 2008; 23(1): 8 doi: 10.1111/j.1440-1746.2007.05249.x
|
22 |
Kajal Nagpal, Fatimah Jan, Uditi Handa, Priyanka Kriplani, Rameshwar Dass, Sheetal Soni, Deepak K. Yadav, Kumar Guarve, Sheetal Devi. ESTIMATING THE RELEASE EFFECT ON BSC-I DRUG BY USING A COMBINATION OF METHYLCELLULOSE AND EUDRAGIT® S-100 POLYMERS TO FORMULATE MINI-FLOATING TABLETS. INDIAN DRUGS 2024; 61(03): 40 doi: 10.53879/id.61.03.14203
|
23 |
Kenji Koshino, Kyoichi Adachi, Kenji Furuta, Shunji Ohara, Terumi Morita, Shuji Nakata, Takashi Tanimura, Masaharu Miki, Yoshikazu Kinoshita. Effects of mosapride on esophageal functions and gastroesophageal reflux. Journal of Gastroenterology and Hepatology 2010; 25(6): 1066 doi: 10.1111/j.1440-1746.2010.06280.x
|
24 |
T. Hershcovici, H. Mashimo, R. Fass. The lower esophageal sphincter. Neurogastroenterology & Motility 2011; 23(9): 819 doi: 10.1111/j.1365-2982.2011.01738.x
|
25 |
K. Blondeau. Treatment of gastro‐esophageal reflux disease: the new kids to block. Neurogastroenterology & Motility 2010; 22(8): 836 doi: 10.1111/j.1365-2982.2010.01537.x
|
26 |
Kazunari Tominaga, Ryuichi Iwakiri, Kazuma Fujimoto, Yasuhiro Fujiwara, Mio Tanaka, Yasuyuki Shimoyama, Eiji Umegaki, Kazuhide Higuchi, Motoyasu Kusano, Tetsuo Arakawa. Rikkunshito improves symptoms in PPI-refractory GERD patients: a prospective, randomized, multicenter trial in Japan. Journal of Gastroenterology 2012; 47(3): 284 doi: 10.1007/s00535-011-0488-5
|
27 |
Heon-Woo Lee, Ji-Hyung Seo, Seung-Ki Choi, Kyung-Tae Lee. Determination of itopride in human plasma by liquid chromatography coupled to tandem mass spectrometric detection: Application to a bioequivalence study. Analytica Chimica Acta 2007; 583(1): 118 doi: 10.1016/j.aca.2006.09.061
|
28 |
Joel E. Richter, Roberto Penagini, Daniel Pohl, Katerina Dvorak, Aaron Goldman, Edoardo Savarino, Patrizia Zentilin, Vincenzo Savarino, Joshua T. Watson, Roy K.H. Wong, Fabio Pace, Valentina Casini, David A. Peura, Shoshana Joy Herzig, Takeshi Kamiya, Iva Pelosini, Carmelo Scarpignato, David Armstrong, Kenneth R. DeVault, Paolo Bechi, Antonio Taddei, Giancarlo Freschi, Maria Novella Ringressi, Duccio Rossi Degli'Innocenti, Francesca Castiglione, Emmanuella Masini, Richard H. Hunt. Barrett's esophagus: proton pump inhibitors and chemoprevention II. Annals of the New York Academy of Sciences 2011; 1232(1): 114 doi: 10.1111/j.1749-6632.2011.06048.x
|
29 |
V.S. Thiruvengada Rajan, T.S. Mohamed Saleem, S. Ramkanth, M. Alagusundaram, K. Ganaprakash, C. Madhusudhana Chetty. A Simple RP-HPLC Method for Quantitation of Itopride HCl in Tablet Dosage Form. Journal of Young Pharmacists 2010; 2(4): 410 doi: 10.4103/0975-1483.71634
|
30 |
V. T. Ivashkin, I. V. Maev, A. S. Trukhmanov, T. L. Lapina, O. A. Storonova, O. V. Zayratyants, O. B. Dronova, Yu. A. Kucheryavyy, S. S. Pirogov, R. G. Sayfutdinov, Yu. P. Uspenskiy, A. A. Sheptulin, D. N. Andreev, D. E. Rumyantseva. Recommendations of the Russian Gastroenterological Association in Diagnosis and Treatment of Gastroesophageal Reflux Disease. Russian Journal of Gastroenterology, Hepatology, Coloproctology 2020; 30(4): 70 doi: 10.22416/1382-4376-2020-30-4-70-97
|
31 |
Zhiwei Hu, Jimin Wu, Zhonggao Wang, Xinghua Bai, Yu Lan, Kefang Lai, Abudureyimu Kelimu, Feng Ji, Zhenling Ji, Diyu Huang, Zhiwei Hu, Xiaohua Hou, Jianyu Hao, Zhining Fan, Xiaoping Chen, Dong Chen, Shengliang Chen, Jinrang Li, Junxiang Li, Lan Li, Peng Li, Zhigang Li, Lin Lin, Bianying Liu, Dian-gang Liu, Yiping Lu, Bin Lü, Qiuping Lü, Ming Qiu, Zhongmin Qiu, Huajao Shen, Jun Tai, Yanping Tang, Wen Tian, Zhonghao Wang, Bangmao Wang, Jian-an Wang, Ju Wang, Qi Wang, Songling Wang, Wen Wang, Zhifei Wang, Wei Wei, Zhiwei Wu, Wei Wu, YanQiao Wu, Yu Wu, Jixiang Wu, Yinglian Xiao, Wen Xu, Xiwei Xu, Fuquan Yang, HuiQi Yang, Yunsheng Yang, Qiyuan Yao, Chunzhao Yu, Peng Zhang, Xiaolan Zhang, Taicheng Zhou, Duowu Zou. Chinese consensus on multidisciplinary diagnosis and treatment of gastroesophageal reflux disease 2022. Gastroenterology & Endoscopy 2023; 1(2): 33 doi: 10.1016/j.gande.2023.01.001
|
32 |
Trilochan Satapathy, Prasana K. Panda, Amit K. Goyal, Goutam Rath. Evaluation of Anti-GERD Activity of Gastro Retentive Drug Delivery System of Itopride Hydrochloride. Artificial Cells, Blood Substitutes, and Biotechnology 2010; 38(4): 200 doi: 10.3109/10731191003776751
|
33 |
Usha Dutta, David Armstrong. Novel Pharmaceutical Approaches to Reflux Disease. Gastroenterology Clinics of North America 2013; 42(1): 93 doi: 10.1016/j.gtc.2012.12.001
|
34 |
Sagar Suman Panda, Subham Panigrahi, Sonal Mohanty, Ravi Kumar Venkata Varaha Bera, Suman Kumar Mekap. Liquid chromatographic methods for simultaneous quantification of fixed‐dose combinations of pantoprazole with itopride and ondansetron: Application to method greenness assessment. SEPARATION SCIENCE PLUS 2023; 6(5) doi: 10.1002/sscp.202300007
|
35 |
Kwang Jae Lee, Jin Il Kim, Ju Sang Park, Byung Sik Moon, Sang-Gyun Kim, Jae Hee Chun, Hoon-Yong Jung, Chang Hwan Choi, Seong Woo Chun, Geun Am Song, Myung Gyu Choi, Hoon Jai Chun. Practice Pattern of Gastroenterologists for the Management of GERD Under the Minimal Influence of the Insurance Reimbursement Guideline: A Multicenter Prospective Observational Study. Journal of Korean Medical Science 2011; 26(12): 1613 doi: 10.3346/jkms.2011.26.12.1613
|
36 |
Yao-Kuang Wang, Wen-Hung Hsu, Sophie S. W. Wang, Chien-Yu Lu, Fu-Chen Kuo, Yu-Chung Su, Sheau-Fang Yang, Chiao-Yun Chen, Deng-Chyang Wu, Chao-Hung Kuo. Current Pharmacological Management of Gastroesophageal Reflux Disease. Gastroenterology Research and Practice 2013; 2013: 1 doi: 10.1155/2013/983653
|
37 |
|
38 |
Jan Tack, Pieter Janssen. Emerging drugs for functional dyspepsia. Expert Opinion on Emerging Drugs 2011; 16(2): 283 doi: 10.1517/14728214.2011.558502
|
39 |
F.M. Huerta-Iga, J.L. Tamayo-de la Cuesta, A. Noble-Lugo, J.M. Remes-Troche, M.A. Valdovinos-Díaz, R.I. Carmona-Sánchez. Consenso mexicano de enfermedad por relujo gastroesofágico. Parte I. Revista de Gastroenterología de México 2012; 77(4): 193 doi: 10.1016/j.rgmx.2012.10.002
|
40 |
Emidio Scarpellini, Daphne Ang, Ans Pauwels, Adriano De Santis, Tim Vanuytsel, Jan Tack. Management of refractory typical GERD symptoms. Nature Reviews Gastroenterology & Hepatology 2016; 13(5): 281 doi: 10.1038/nrgastro.2016.50
|
41 |
Tiberiu Hershcovici, Ronnie Fass. Pharmacological management of GERD: where does it stand now?. Trends in Pharmacological Sciences 2011; 32(4): 258 doi: 10.1016/j.tips.2011.02.007
|
42 |
Albina Ayratovna Zvegintseva, Lyudmila Yurievna Kulagina, Maksim Leonidovich Maksimov, E.V. Matveev. The features of GERD pharmacotherapy. Vrač skoroj pomoŝi (Emergency Doctor) 2021; (9): 5 doi: 10.33920/med-02-2109-01
|
43 |
Maria Janiak. Itopride in treatment of laryngopharyngeal symptoms of gastroesophageal reflux disease. Otolaryngologia Polska 2021; 75(6): 38 doi: 10.5604/01.3001.0015.5165
|
44 |
Onyekachi Oluchi Enwereuzo, Obinna Chigoziem Akakuru, Romanus Chinonso Uwaoma, Elias Emeka Elemike, Ozioma Udochukwu Akakuru. Self-assembled membrane-polymer nanoparticles of top-notch tissue tolerance for the treatment of gastroesophageal reflux disease. Journal of Nanostructure in Chemistry 2021; 11(4): 707 doi: 10.1007/s40097-021-00394-w
|
45 |
Ege Altan, Kathleen Blondeau, Ans Pauwels, Ricard Farré, Jan Tack. Evolving pharmacological approaches in gastroesophageal reflux disease. Expert Opinion on Emerging Drugs 2012; 17(3): 347 doi: 10.1517/14728214.2012.702753
|
46 |
J. Tack, A. Masclee, R. Heading, A. Berstad, H. Piessevaux, T. Popiela, A. Vandenberghe, H. Kato. A dose‐ranging, placebo‐controlled, pilot trial of Acotiamide in patients with functional dyspepsia. Neurogastroenterology & Motility 2009; 21(3): 272 doi: 10.1111/j.1365-2982.2009.01261.x
|